Common Drug Classes

Why This Matters

In pharmacology, you're not just memorizing drug names. You're learning to think in terms of mechanisms of action, therapeutic goals, and monitoring parameters. Every drug class on this list represents a different strategy for intervening in the body's physiology, whether that's blocking a receptor, inhibiting an enzyme, or altering ion movement across cell membranes. Understanding why a drug works helps you predict its effects, side effects, and interactions.

Exams will test your ability to connect drug classes to their mechanisms, identify appropriate monitoring parameters, and recognize when one drug might be preferred over another. Don't just memorize that "beta-blockers treat hypertension." Know that they work by reducing cardiac output and renin release, which is why they're also useful for heart failure and certain anxiety symptoms. That kind of conceptual thinking is what separates strong exam performance from rote memorization.

---

Drugs That Modulate Pain and Inflammation

Pain management is one of the most fundamental applications of pharmacology. These drugs work through different mechanisms: blocking prostaglandin synthesis, activating opioid receptors, or both. Understanding these pathways helps you predict both therapeutic effects and adverse reactions.

Analgesics

• Two major categories: opioid and non-opioid. Opioids (morphine, oxycodone) bind to mu receptors in the CNS to block pain signaling. Non-opioids (acetaminophen) work primarily through central mechanisms without anti-inflammatory effects.
• Opioid dependence and respiratory depression are the critical safety concerns. You'll need to monitor respiratory rate and sedation level closely, and doses should be titrated carefully.
• Non-opioids are first-line for mild to moderate pain. They avoid the dependence risk and are often combined with opioids for synergistic effects in moderate-to-severe pain.

Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

• Inhibit cyclooxygenase (COX) enzymes. Blocking prostaglandin synthesis provides a triple effect: analgesia, anti-inflammatory action, and antipyretic activity.
• GI bleeding and renal impairment are the major adverse effects. This makes sense once you know that prostaglandins normally protect the gastric mucosa and help maintain renal blood flow. Block prostaglandins, and you lose those protections.
• Common examples include ibuprofen and naproxen. COX-2 selective inhibitors (celecoxib) reduce GI risk but carry increased cardiovascular concerns.

---

Drugs That Target the Cardiovascular System

Cardiovascular pharmacology centers on four key goals: controlling blood pressure, preventing clots, managing heart rhythm, and reducing atherosclerosis. These drugs often work together, and understanding their mechanisms helps you anticipate both therapeutic synergy and dangerous interactions.

Antihypertensives

Multiple drug classes lower blood pressure through distinct mechanisms:

• Diuretics reduce blood volume.
• ACE inhibitors block the renin-angiotensin-aldosterone system (RAAS), preventing the conversion of angiotensin I to angiotensin II.
• Beta-blockers decrease heart rate and cardiac output.
• Calcium channel blockers cause vasodilation by preventing calcium entry into vascular smooth muscle.

Blood pressure monitoring is essential for assessing effectiveness and guiding dose adjustments. First-line choices depend on patient factors: ACE inhibitors are preferred in diabetes (they provide renal protection), beta-blockers in heart failure, and thiazide diuretics in uncomplicated hypertension.

Anticoagulants

• Prevent clot formation through different pathways. Warfarin inhibits vitamin K-dependent clotting factors (II, VII, IX, X), while DOACs (rivaroxaban, apixaban) directly inhibit factor Xa or thrombin.
• Warfarin requires INR monitoring (target typically 2.0-3.0) due to its narrow therapeutic index and numerous drug-food interactions, particularly with vitamin K-rich foods.
• DOACs offer predictable dosing without routine monitoring. However, renal function affects dosing for most DOACs, and reversal agents are limited for some (though andexanet alfa is now available for anti-Xa agents).

Statins

• Inhibit HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis, reducing LDL levels by roughly 30-50% depending on dose and specific agent.
• Atorvastatin and rosuvastatin are common high-intensity options; high-intensity therapy is standard for secondary prevention after cardiovascular events.
• Monitor liver enzymes and muscle symptoms. Myopathy and rhabdomyolysis are rare but serious adverse effects. Patients reporting unexplained muscle pain or weakness need prompt evaluation.

Diuretics

These drugs promote sodium and water excretion at different sites along the nephron:

• Loop diuretics (furosemide) act at the ascending loop of Henle. They're the most potent and are used for acute fluid removal in heart failure.
• Thiazide diuretics (hydrochlorothiazide) act at the distal convoluted tubule. They're preferred for chronic hypertension management.
• Potassium-sparing diuretics (spironolactone) act at the collecting duct. Spironolactone also blocks aldosterone, giving it a role in heart failure.

Electrolyte monitoring is critical. Loop and thiazide diuretics cause hypokalemia, while potassium-sparing diuretics risk hyperkalemia. This distinction comes up frequently on exams.

---

Drugs That Regulate Metabolism and Endocrine Function

Metabolic disorders require drugs that either replace deficient hormones or modify cellular responses to existing hormones. Blood glucose management is a perfect example of how pharmacology must balance efficacy against hypoglycemia risk.

Antidiabetics

• Insulin is essential for Type 1 and often needed in Type 2. It directly facilitates glucose uptake into cells. Formulations range from rapid-acting (lispro, onset ~15 minutes) to long-acting (glargine, ~24-hour duration), allowing flexible dosing regimens.
• Metformin is first-line for Type 2 diabetes. It decreases hepatic glucose production and improves insulin sensitivity. A key advantage: it rarely causes hypoglycemia when used alone. The most common side effects are GI (nausea, diarrhea), and it's contraindicated in severe renal impairment due to lactic acidosis risk.
• Blood glucose monitoring guides therapy adjustments. Target HbA1c is typically <7%, though this is individualized based on patient factors like age, comorbidities, and hypoglycemia risk.

---

Drugs That Fight Infection

Anti-infective pharmacology requires understanding not just what kills pathogens, but how resistance develops and why appropriate use matters for public health.

Antibiotics

Antibiotics work by either killing bacteria (bactericidal) or inhibiting their growth (bacteriostatic). The mechanism of action determines which organisms are susceptible:

• Cell wall synthesis inhibition: Penicillins, cephalosporins. These are bactericidal and most effective against actively dividing bacteria.
• Protein synthesis inhibition: Macrolides (azithromycin), tetracyclines. Generally bacteriostatic.
• DNA replication interference: Fluoroquinolones (ciprofloxacin). Bactericidal with broad-spectrum activity.

Completing the full course prevents resistance. Subtherapeutic exposure allows resistant organisms to survive and proliferate. Spectrum of activity also matters: narrow-spectrum agents target specific bacteria, while broad-spectrum agents are useful empirically but increase resistance risk and can disrupt normal flora.

---

Drugs That Modulate the Central Nervous System

CNS pharmacology involves drugs that alter neurotransmitter activity: increasing, decreasing, or modulating signals at synapses. Many of these drugs have a delayed onset of therapeutic effect and require careful monitoring for both efficacy and adverse effects.

Antidepressants

• SSRIs (fluoxetine, sertraline) are first-line for depression and anxiety. They selectively block serotonin reuptake, increasing synaptic serotonin availability.
• Therapeutic effects take 2-4 weeks to develop. Patients need education about this delay, and close monitoring for worsening symptoms is essential, especially in the early weeks of treatment when energy may return before mood improves.
• Other classes include SNRIs and tricyclics. SNRIs (venlafaxine, duloxetine) add norepinephrine reuptake inhibition. Tricyclics (amitriptyline) are effective but have more anticholinergic side effects and greater overdose toxicity, which is why they're no longer first-line.

Antipsychotics

• Block dopamine D2 receptors to reduce positive symptoms of psychosis (hallucinations, delusions). Atypical agents also affect serotonin receptors, which broadens their therapeutic profile.
• First-generation (typical) vs. second-generation (atypical): Typicals (haloperidol) carry a higher risk of extrapyramidal symptoms (EPS) and tardive dyskinesia. Atypicals (risperidone, olanzapine) have lower EPS risk but higher metabolic risk.
• Monitor for extrapyramidal symptoms and metabolic syndrome. With atypical agents, regular screening for weight gain, glucose intolerance, and lipid abnormalities is standard practice.

Antiepileptics

• Stabilize neuronal membranes through various mechanisms: sodium channel blockade (phenytoin, carbamazepine), GABA enhancement (valproate, benzodiazepines), or calcium channel effects (ethosuximide for absence seizures specifically).
• Drug level monitoring is essential for many agents due to narrow therapeutic indices and significant drug interactions. Phenytoin is a classic example because it exhibits zero-order kinetics at therapeutic doses, meaning small dose changes can cause big swings in blood levels.
• Choice depends on seizure type. Phenytoin and carbamazepine for focal seizures, valproate and lamotrigine for generalized seizures, ethosuximide specifically for absence seizures.

---

Drugs That Affect the Respiratory and GI Systems

These drug classes address common conditions through receptor blockade or enzyme inhibition. Understanding the underlying physiology of allergic responses, bronchoconstriction, and acid secretion clarifies why these drugs work.

Antihistamines

• Block H1 histamine receptors to prevent allergic symptoms. When mast cells release histamine, it causes vasodilation, increased capillary permeability, and itching. H1 blockers prevent these effects.
• First-generation (diphenhydramine) crosses the blood-brain barrier, causing sedation. This can be therapeutic (it's used in OTC sleep aids) or problematic (impaired driving, falls in elderly patients).
• Second-generation (loratadine, cetirizine) are non-sedating because they don't readily cross the blood-brain barrier. They're preferred for daytime allergy management.

Bronchodilators

• Relax bronchial smooth muscle through beta-2 receptor activation (sympathomimetics) or muscarinic receptor blockade (anticholinergics like ipratropium).
• Short-acting beta-agonists (albuterol) are for acute relief. Onset is within minutes, making them the go-to rescue medication for asthma attacks.
• Long-acting agents (salmeterol, tiotropium) are for maintenance. An important safety point: LABAs should never be used alone for asthma. They must always be combined with inhaled corticosteroids because LABAs alone can increase the risk of severe asthma exacerbations.

Proton Pump Inhibitors

• Irreversibly inhibit the gastric $H^+/K^+$ ATPase, the final step in acid secretion. This provides more complete acid suppression than H2 blockers.
• Omeprazole and esomeprazole are common examples. They're most effective when taken 30-60 minutes before meals because the proton pumps need to be actively secreting acid to be inhibited.
• Long-term use concerns include vitamin B12 and magnesium deficiency, increased infection risk (C. difficile), and possible bone fracture risk. These risks are why PPIs should be used at the lowest effective dose for the shortest necessary duration.

Antiemetics

Different causes of nausea call for different receptor targets:

• Serotonin (5-HT3) antagonists (ondansetron): first-line for chemotherapy-induced and post-operative nausea. They block receptors in the chemoreceptor trigger zone.
• Dopamine antagonists (metoclopramide): useful for gastroparesis because they also have prokinetic effects that speed gastric emptying.
• Anticholinergics (scopolamine): best for motion sickness, targeting the vestibular system.

Identifying the underlying cause of nausea guides drug selection. This is a common exam theme.

---

Quick Reference Table

---

Self-Check Questions

1. Which two drug classes both reduce cardiovascular risk but through completely different mechanisms: one by lowering cholesterol synthesis and one by preventing clot formation?

2. A patient on warfarin asks why they need regular blood tests while their neighbor on apixaban doesn't. How would you explain the difference in monitoring requirements based on their mechanisms?

3. Compare first-generation and second-generation antihistamines: what property makes second-generation agents preferred for daytime use, and what is the pharmacokinetic reason for this difference?

4. If a patient with Type 2 diabetes is started on metformin, why is hypoglycemia less of a concern compared to a patient started on insulin? What mechanism explains this difference?

5. An exam question describes a patient with asthma using their albuterol inhaler multiple times daily. What does this pattern indicate about their disease control, and what class of medication should be added to their regimen?